piperacillin, tazobactam

Generic: piperacillin sodium, tazobactam sodium

Labeler: sagent pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name piperacillin, tazobactam
Generic Name piperacillin sodium, tazobactam sodium
Labeler sagent pharmaceuticals
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

piperacillin sodium 36 g/152mL, tazobactam sodium 4.5 g/152mL

Manufacturer
Sagent Pharmaceuticals

Identifiers & Regulatory

Product NDC 25021-181
Product ID 25021-181_a6724256-14c5-4408-83a5-a964f146f0d5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208675
Listing Expiration 2026-12-31
Marketing Start 2021-02-28

Pharmacologic Class

Classes
penicillin-class antibacterial [epc] penicillins [cs] beta lactamase inhibitor [epc] beta lactamase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 25021181
Hyphenated Format 25021-181

Supplemental Identifiers

RxCUI
312447
UNII
M98T69Q7HP UXA545ABTT

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name piperacillin, tazobactam (source: ndc)
Generic Name piperacillin sodium, tazobactam sodium (source: ndc)
Application Number ANDA208675 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 36 g/152mL
  • 4.5 g/152mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (25021-181-99) / 152 mL in 1 BOTTLE
source: ndc

Packages (1)

25021-181-99 1 BOTTLE in 1 CARTON (25021-181-99) / 152 mL in 1 BOTTLE

Ingredients (2)

piperacillin sodium (36 g/152mL) tazobactam sodium (4.5 g/152mL)

Linked Drug Pages (1)

Piperacillin, Tazobactam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "a6724256-14c5-4408-83a5-a964f146f0d5", "openfda": {"unii": ["M98T69Q7HP", "UXA545ABTT"], "rxcui": ["312447"], "spl_set_id": ["83f4adcd-893c-4e9e-8f2b-e06299dcf34d"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (25021-181-99)  / 152 mL in 1 BOTTLE", "package_ndc": "25021-181-99", "marketing_start_date": "20210228"}], "brand_name": "Piperacillin, Tazobactam", "product_id": "25021-181_a6724256-14c5-4408-83a5-a964f146f0d5", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "25021-181", "generic_name": "Piperacillin Sodium, Tazobactam Sodium", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin, Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "36 g/152mL"}, {"name": "TAZOBACTAM SODIUM", "strength": "4.5 g/152mL"}], "application_number": "ANDA208675", "marketing_category": "ANDA", "marketing_start_date": "20210228", "listing_expiration_date": "20261231"}